InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Thursday, 07/25/2019 10:58:45 AM

Thursday, July 25, 2019 10:58:45 AM

Post# of 892
Multiple catalysts on the way in 2nd half of 2019,

Two pivotal trial initiations for pancreatic cancer - 2nd line and 3rd line respectively.

Preclinical data from 15 types of cancer using SM-88

Final Prostate cancer data expected

IND to begin studying TYME-18 product for intratumoral injection

So many irons in the fire, TYME still way undervalued with a low market cap